GP350 CAR-T
/ Zeno Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 30, 2025
ANXIN-02: GP350 CAR-T for Relapse/Refractory and Epstein-Barr Virus Infection Associated Lymphoid Neoplasms
(clinicaltrials.gov)
- P1/2 | N=24 | Recruiting | Sponsor: Zhimin Zhai
New P1/2 trial • Epstein-Barr Virus Infections • Hematological Malignancies • Infectious Disease • Oncology
1 to 1
Of
1
Go to page
1